12 results
8-K
EX-99.2
KRYS
Krystal Biotech Inc
26 Jul 23
Krystal Biotech Announces Pipeline Expansion into Oncology
4:01pm
IL-2 and IL-12 detected in cell culture supernatants 24 hours after transduction at MOI of 1 IL-12: Over 3,000 ng / mL IL-2: Over 400 ng / mL KB707
8-K
EX-99.1
30eh2y12t3b5rwa3ecs
20 May 22
Regulation FD Disclosure
8:26am
8-K
EX-99.1
jipu9z69jyqlshzhlk0
28 Mar 22
Regulation FD Disclosure
4:06pm
8-K
EX-99.2
nhfn2
9 Aug 21
Krystal Biotech Reports Second Quarter 2021 Financial Results and Provides Update on Operational Progress
4:02pm
8-K
EX-99.2
t8a7whuajm hllhw9tt
1 Jul 21
Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the Treatment of TGM-1 Associated Ichthyosis
5:31pm
8-K
EX-99.1
8r51t13
7 Jan 21
Regulation FD Disclosure
8:02am
8-K
EX-99.3
1hugm boc1fziju6ypvm
9 Nov 20
Krystal Biotech Reports Third Quarter 2020 Financial Results and Provides Update on Operational Progress
8:32am
10-K
6ltf1nrxret
12 Mar 18
Annual report
12:00am
- Prev
- 1
- Next